Applications of DL-Erythro-Dihydrosphingosine in Industrial Manufacturing

As a dedicated manufacturer of DL-Erythro-Dihydrosphingosine, we supply this high-purity sphingoid base directly to specialized industrial sectors where it serves essential roles in formulation and production. Our material supports advanced synthesis, formulation enhancement, and quality control for downstream partners with strict compliance and traceability requirements. The following applications reflect current real-world integration along established supply chains, demonstrating concrete end uses and manufacturing practices.

1. Ceramide Synthesis for Cosmetic and Dermatological Formulations

Leading personal care manufacturers use DL-Erythro-Dihydrosphingosine as a primary intermediate in in-house synthesis of various ceramides, which they incorporate into moisturizing lotions, skin barrier ointments, and anti-aging treatments. This compound enters the synthetic route as a sphingoid backbone, supporting batches formulated for precise lipid chain length and unsaturation profiles tailored to meet global skin care trends as well as allergen safety requirements. Its use enables downstream formulators to control product texture, bioavailability, and compatibility for sensitive skin applications.

Industry compliance standards

• ISO 22716 (Cosmetic GMP)
• EU Cosmetics Regulation (EC) No 1223/2009
• US FDA Cosmetic Ingredient Review (CIR)
• Allergen and preservative-free claims verified according to IECIC (China)

Typical usage ratio

• 0.01%–0.5% w/w in final topical formulation; adjusted based on target ceramide concentration and texture demands

Downstream process integration

• Added during sphingolipid synthesis prior to acylation step; purified ceramide then blended into oil phase or emulsion in the late formulation stages

Final product types

• Facial creams for barrier repair
• Body lotions for atopic skin
• High-end anti-aging serums
• Dermatological lipid-replenishing ointments

2. Analytical Reference Standard in Pharmaceutical Quality Testing

Pharmaceutical companies and advanced analytical laboratories use DL-Erythro-Dihydrosphingosine as a reference standard for LC-MS/MS and HPLC assays. Accurate quantification of endogenous sphingolipids in biological matrices relies on traceable, high-purity standards for calibration and validation. This raw material supports routine batch release analytics, stability studies, and method development for drug R&D and clinical trials, ensuring data consistency and regulatory submission acceptance.

Industry compliance standards

• USP General Chapter <621> Chromatography
• ICH Q2(R1) Validation of Analytical Procedures
• US FDA 21 CFR Part 211 (cGMP for finished pharmaceuticals)
• ISO/IEC 17025 for testing laboratories proficiency

Typical usage ratio

• Precise µg/mL concentrations, typically 0.05–5.0 µg/mL in standard solution; final amount based on method sensitivity and matrix interference studies

Downstream process integration

• Dissolved in HPLC-grade solvents for use as calibration standards, recovery controls, and reference materials during analytical sequence programming

Final product types

• Reference materials kits for clinical analytics
• Validation standards for pharmaceutical method development
• Batch-release QC documentation for sphingolipid-based APIs
• Certified reference standards for regulated markets

3. Liposome and Nanocarrier Fabrication in Advanced Drug Delivery

Formulators of next-generation drug-delivery systems utilize this material as an amphiphilic building block during the construction of custom lipid vesicles and nanoemulsions intended for targeted pharmaceutical applications. DL-Erythro-Dihydrosphingosine is incorporated to influence bilayer fluidity, encapsulation efficiency, and controlled release profiles in small-scale and GMP-compliant nanoformulation lines. This approach is crucial for peptide, mRNA, or hydrophobic drug payloads where conventional phospholipids alone may limit stability or release performance.

Industry compliance standards

• European Pharmacopoeia (Ph. Eur.) monographs for excipients
• US FDA Inactive Ingredient Database (IID) for parenteral products
• ICH Q8 (Pharmaceutical Development) and ICH Q10 (Pharmaceutical Quality System)
• GMP guidelines for sterile manufacturing (e.g., WHO TRS 961, Annex 6)

Typical usage ratio

• 1–8 mol% relative to total lipid content in vesicle formulation; selection optimized by drug type and desired membrane rigidity

Downstream process integration

• Blended with other synthetic or natural lipids in organic solvent, followed by thin-film hydration, extrusion, or high-shear mixing to prepare nanocarriers

Final product types

• Liposomal injectable suspensions for targeted therapies
• Lipid nanoparticle (LNP) carriers for mRNA vaccines
• Oral or topical nanocarrier gels containing active pharmaceutical ingredients
• Stability-tested lipid vesicle formulations for research or clinical trials

4. Sphingolipid Enzyme Substrate in Biochemical Research Reagents

Our material provides research reagent manufacturers with a controlled, high-purity sphingoid base essential for downstream enzyme assay kits, which support academic and pharmaceutical investigations into sphingolipid metabolism, signaling, and lysosomal storage diseases. In this application, DL-Erythro-Dihydrosphingosine is dispensed as the substrate for ceramide synthase and related enzyme studies, where batch consistency and traceability are paramount for experimental reproducibility and publication integrity.

Industry compliance standards

• ISO 13485 for medical device components used in IVD reagent manufacturing
• REACH registration for chemical safety in Europe
• US NIH guidelines for research-use-only reagents
• GLP (Good Laboratory Practice) for biochemical assay development

Typical usage ratio

• 10–200 µM final assay concentration; adjusted depending on enzyme activity and detection method sensitivity

Downstream process integration

• Aliquoted into assay component kits, lyophilized or dissolved as a substrate standard, and included in packaged enzymatic testing reagents

Final product types

• Enzyme activity measurement kits for ceramide synthase or kinase
• Sphingolipid quantification assay kits for biochemical research
• Metabolomics standards for cell signaling studies
• Specialty reagents for rare disease diagnostic research